1 |
Trivedi, N.R., Rajan, M.G., Johnson, J.R., Shukla, A.J., 2007. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit. Rev. Ther. Drug Carrier Syst. 24, 1-40.
DOI
ScienceOn
|
2 |
Tuleu, C., Newton, M., Rose, J., Euler, D., Saklatvala, R., Clarke, A., Booth, S., 2004. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci. 93, 1495-1502.
DOI
|
3 |
Vergote, G.J., Kiekens, F., Vervaet, C., Remon, J.P., 2002. Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur. J. Pharm. Sci. 17, 145-151.
DOI
|
4 |
Wagner, K.G., Krumme, M., Schmidt, P.C., 2000. Pellet-containing tablets examination of distribution and deformation behaviour. STP Pharm. Sci. 10, 327-334.
|
5 |
Wang, L., Wang, J., Lin, X., Tang, X., 2010a. Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability. Drug Dev. Ind. Pharm. 36, 814-822.
DOI
|
6 |
Wang, Z., Sun, J., Wang, Y., Liu, X., Liu, Y., Fu, Q., Meng, P., He, Z., 2010b. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 383, 1-6.
DOI
ScienceOn
|
7 |
Williams, R.O., 3rd, Liu, J., 2000. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. Eur. J. Pharm. Biopharm. 49, 243-252.
DOI
|
8 |
Pund, S., Joshi, A., Vasu, K., Nivsarkar, M., Shishoo, C., 2010. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. Int. J. Pharm. 388, 64-72.
DOI
|
9 |
Rahman, M.A., Ahuja, A., Baboota, S., Bhavna, Bali, V., Saigal, N., Ali, J., 2009. Recent advances in pelletization technique for oral drug delivery: a review. Curr. Drug Deliv. 6, 122-129.
DOI
|
10 |
Sawicki, W., Lunio, R., 2005. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D. Eur. J. Pharm. Biopharm. 60, 153-158.
DOI
|
11 |
Scala-Bertola, J., Gajdziok, J., Rabiskova, M., Bonneaux, F., Lecompte, T., Sapin, A., Maincent, P., 2009. Pellets for oral administration of low-molecular-weight heparin. Drug Dev. Ind. Pharm. 35, 1503-1510.
DOI
|
12 |
Serratoni, M., Newton, M., Booth, S., Clarke, A., 2007. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur. J. Pharm. Biopharm. 65, 94-98.
DOI
|
13 |
Shavi, G.V., Nayak, U., Averineni, R.K., Arumugam, K., Meka, S.R., Nayanabhirama, U., Sureshwar, P., 2009. Multiparticulate drug delivery system of aceclofenac: development and in vitro studies. Drug Dev. Ind. Pharm. 35, 252-258.
DOI
ScienceOn
|
14 |
Siepmann, F., Muschert, S., Flament, M.P., Leterme, P., Gayot, A., Siepmann, J., 2006. Controlled drug release from Gelucirebased matrix pellets: experiment and theory. Int. J. Pharm. 317, 136-143.
DOI
|
15 |
Sinha, V.R., Agrawal, M.K., Agarwal, A., Singh, G., Ghai, D., 2009. Extrusion-spheronization: process variables and characterization. Crit. Rev. Ther. Drug Carrier Syst. 26, 275-331.
DOI
ScienceOn
|
16 |
Sungthongjeen, S., Paeratakul, O., Limmatvapirat, S., Puttipipatkhachorn, S., 2006. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int. J. Pharm. 324, 136-143.
DOI
ScienceOn
|
17 |
Mezreb, N., Charrueau, C., Boy, P., Allain, P., Chaumeil, J.C., 2004. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content. Drug Dev. Ind. Pharm. 30, 481-490.
DOI
|
18 |
Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2000. Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. J. Control. Release 63, 201-211.
DOI
ScienceOn
|
19 |
Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2001. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int. J. Pharm. 213, 7-12.
DOI
|
20 |
Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2002. Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: characterization of release mechanisms. Drug Dev. Ind. Pharm. 28, 275-285.
DOI
|
21 |
Montousse, C., Pruvost, M., Rodriguez, F., Brossard, C., 1999. Extrusion-spheronization manufacture of Gelucire matrix beads. Drug Dev. Ind. Pharm. 25, 75-80.
DOI
|
22 |
Newton, M., Petersson, J., Podczeck, F., Clarke, A., Booth, S., 2001. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90, 987-995.
DOI
|
23 |
Panchagnula, R., Gupta, A., Kandavilli, S., Varma, M.V., 2006. High-throughput evaluation of non-swellable controlled release matrix tablets. Drug Dev. Ind. Pharm. 32, 669-675.
DOI
|
24 |
Pieszczek, B., Jachowicz, R., 2010. The effect of physico-chemical properties of the drug on the pharmaceutical availability of piroxicam from pellets. Pharm. Dev. Technol. 15, 241-248.
DOI
|
25 |
Kojima, M., Nakagami, H., 2002. Development of controlled release matrix pellets by annealing with micronized waterinsoluble or enteric polymers. J. Control. Release 82, 335-343.
DOI
|
26 |
Karrout, Y., Neut, C., Wils, D., Siepmann, F., Deremaux, L., Flament, M.P., Dubreuil, L., Desreumaux, P., Siepmann, J., 2009. Novel polymeric film coatings for colon targeting: Drug release from coated pellets. Eur. J. Pharm. Sci. 37, 427-433.
DOI
|
27 |
Kibria, G., Islam, K.M., Jalil, R.U., 2009. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer. Pak. J. Pharm. Sci. 22, 36-43.
|
28 |
Kilor, V.A., Sapkal, N.P., Awari, J.G., Shewale, B.D., 2010. Development and characterization of enteric-coated immediaterelease pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent. AAPS PharmSciTech 11, 336-343.
DOI
|
29 |
Krogars, K., Heinamaki, J., Vesalahti, J., Marvola, M., Antikainen, O., Yliruusi, J., 2000. Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. Int. J. Pharm. 199, 187-194.
DOI
|
30 |
Liu, Y., Schwartz, J.B., Schnaare, R.L., 2003. A multimechanistic drug release approach in a bead dosage form and in vitro predictions. Pharm. Dev. Technol. 8, 163-173.
DOI
|
31 |
Mallipeddi, R., Saripella, K.K., Neau, S.H., 2010. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int. J. Pharm. 385, 53-65.
DOI
|
32 |
Mayo-Pedrosa, M., Alvarez-Lorenzo, C., Lacik, I., Martinez-Pacheco, R., Concheiro, A., 2007. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems. J. Pharm. Sci. 96, 93-105.
DOI
|
33 |
Ghosh, P.K., Murthy, R.S., 2006. Microemulsions: a potential drug delivery system. Current Drug Delivery 3, 167-180.
DOI
|
34 |
Fekete, R., Zelko, R., Marton, S., Racz, I., 1998. Effect of the formulation parameters on the characteristics of pellets. Drug Dev Ind Pharm 24, 1073-1076.
DOI
|
35 |
Freire, C., Podczeck, F., Veiga, F., Sousa, J., 2010. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery. Drug Dev. Ind. Pharm. 36, 161-172.
DOI
|
36 |
Ghaffari, A., Avadi, M.R., Moghimi, H.R., Oskoui, M., Bayati, K., Rafiee-Tehrani, M., 2008. Mechanistic analysis of drug release from theophylline pellets coated by films containing pectin, chitosan and Eudragit RS. Drug Dev. Ind. Pharm. 34, 390-402.
DOI
|
37 |
Gursoy, R.N., Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & Pharmacotherapy 58, 173-182.
DOI
|
38 |
Huang, Y.T., Tsai, T.R., Cheng, C.J., Cham, T.M., Lai, T.F., Chuo, W.H., 2007. Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. Drug Dev. Ind. Pharm. 33, 403-416.
DOI
|
39 |
Iosio, T., Voinovich, D., Grassi, M., Pinto, J.F., Perissutti, B., Zacchigna, M., Quintavalle, U., Serdoz, F., 2008. Bi-layered selfemulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur. J. Pharm. Biopharm. 69, 686-697.
DOI
|
40 |
Jachowicz, R., Nurnberg, E., Pieszczek, B., Kluczykowska, B., Maciejewska, A., 2000. Solid dispersion of ketoprofen in pellets. Int. J. Pharm. 206, 13-21.
DOI
|
41 |
Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60, 1281-1302.
DOI
|
42 |
Brachkova, M.I., Duarte, A., Pinto, J.F., 2009. Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms. J. Pharm. Sci. 98, 3329-3339.
DOI
|
43 |
Bruce, L.D., Petereit, H.U., Beckert, T., McGinity, J.W., 2003. Properties of enteric coated sodium valproate pellets. Int. J. Pharm. 264, 85-96.
DOI
|
44 |
Chi, N., Guo, J.H., Zhang, Y., Zhang, W., Tang, X., 2010. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer. Pharm. Dev. Technol. 15, 97-104.
DOI
|
45 |
Chivate, A.A., Poddar, S.S., 2008. Designing, optimisation & characterization of sustained release matrix pellets prepared by extrusion spheronization containing mixture of proteolytic enzymes. Curr. Drug Deliv. 5, 265-274.
DOI
|
46 |
Chuong, M.C., Christensen, J.M., Ayres, J.W., 2009. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis. Pharm. Dev. Technol. 14, 116-125.
|
47 |
Dashevsky, A., Kolter, K., Bodmeier, R., 2004. Compression of pellets coated with various aqueous polymer dispersions. Int. J. Pharm. 279, 19-26.
DOI
|
48 |
Debunne, A., Vervaet, C., Remon, J.P., 2002. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs. Eur. J. Pharm. Biopharm. 54, 343-348.
DOI
|
49 |
el-Mahdi, I.M., Deasy, P.B., 2000. Tableting of coated ketoprofen pellets. J. Microencapsul. 17, 133-144.
DOI
|
50 |
Elchidana, P.A., Deshpande, S.G., 1999. Microporous membrane
drug delivery system for indomethacin. J. Control. Release 59, 279-285.
DOI
|
51 |
Abbaspour, M.R., Sadeghi, F., Afrasiabi Garekani, H., 2007. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting. Eur. J. Pharm. Biopharm. 67, 260-267.
DOI
|
52 |
Abdalla, A., Klein, S., Mader, K., 2008. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci. 35, 457-464.
DOI
|
53 |
Abdalla, A., Mader, K., 2007. Preparation and characterization of a self-emulsifying pellet formulation. Eur. J. Pharm. Biopharm. 66, 220-226.
DOI
|
54 |
Awad, G.A.S., Charrueau, C.A.A., Allain, P., Chaumeil, J.C., 2002. Formulation and evaluation of bioadhesive pellets containing different carbomers made by extrusion-spheronization. STP Pharm. Sci. 12, 157-162.
|
55 |
Bendas, E.R., Ayres, J.W., 2008. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data. Eur. J. Pharm. Biopharm. 69, 977-985.
DOI
|
56 |
Bendas, E.R., Christensen, J.M., Ayres, J.W., 2010. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets. Drug Dev. Ind. Pharm. 36, 393-404.
DOI
|
57 |
Zeeshan, F., Peh, K.K., Tan, Y.T., 2009. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug. AAPS PharmSciTech 10, 850-857.
DOI
|
58 |
Bodmeier, R., 1997. Tableting of coated pellets. Eur. J. Pharm. Biopharm. 43, 1-8.
DOI
|
59 |
Wiwattanapatapee, R., Pengnoo, A., Kanjanamaneesathian, M., Matchavanich, W., Nilratana, L., Jantharangsri, A., 2004. Floating pellets containing bacterial antagonist for control sheath blight of rice: formulations, viability and bacterial release studies. J. Control. Release 95, 455-462.
DOI
|
60 |
Zeeshan, F., Bukhari, N.I., 2010. Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs. AAPS PharmSciTech 11, 910-916.
DOI
|
61 |
Zhang, X., Tang, X., Yang, R., 2009. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev. Ind. Pharm. 35, 26-33.
DOI
|
62 |
Talegaonkar, S., Azeem, A., Ahmad, F.J., Khar, R.K., Pathan, S.A., Khan, Z.I., 2008. Microemulsions: a novel approach to enhanced drug delivery. Recent Patents on Drug Delivery & Formulation 2, 238-257.
DOI
|
63 |
Tian, L., Zhang, Y., Tang, X., 2008. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs. Drug Dev. Ind. Pharm. 34, 569-576.
DOI
|